349 related articles for article (PubMed ID: 31627123)
1. Prebiotics and probiotics as potential therapy for cognitive impairment.
Romo-Araiza A; Ibarra A
Med Hypotheses; 2020 Jan; 134():109410. PubMed ID: 31627123
[TBL] [Abstract][Full Text] [Related]
2. [Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment].
Shikh EV; Nikolaeva NB; Molchanova NB; Elizarova EV
Vopr Pitan; 2023; 92(6):107-119. PubMed ID: 38198424
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
5. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
6. Interactions of probiotics and prebiotics with the gut microbiota.
Ballan R; Battistini C; Xavier-Santos D; Saad SMI
Prog Mol Biol Transl Sci; 2020; 171():265-300. PubMed ID: 32475525
[TBL] [Abstract][Full Text] [Related]
7. [The gut microbiota, a new cardiovascular risk factor?].
Chong-Nguyen C; Duboc H; Sokol H
Presse Med; 2017; 46(7-8 Pt 1):708-713. PubMed ID: 28756077
[TBL] [Abstract][Full Text] [Related]
8. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
11. Sleep apnoea, gut dysbiosis and cognitive dysfunction.
Deyang T; Baig MAI; Dolkar P; Hediyal TA; Rathipriya AG; Bhaskaran M; PandiPerumal SR; Monaghan TM; Mahalakshmi AM; Chidambaram SB
FEBS J; 2024 Jun; 291(12):2519-2544. PubMed ID: 37712936
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
13. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
14. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
[TBL] [Abstract][Full Text] [Related]
15. Probiotics, prebiotics and colorectal cancer prevention.
Ambalam P; Raman M; Purama RK; Doble M
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
[TBL] [Abstract][Full Text] [Related]
16. Emerging Evidence on the Use of Probiotics and Prebiotics to Improve the Gut Microbiota of Older Adults with Frailty Syndrome: A Narrative Review.
Sánchez Y Sánchez de la Barquera B; Martínez Carrillo BE; Aguirre Garrido JF; Martínez Méndez R; Benítez Arciniega AD; Valdés Ramos R; Soto Piña AE
J Nutr Health Aging; 2022; 26(10):926-935. PubMed ID: 36259581
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiome as a Possible Cause of Occurrence and Therapeutic Target in Chronic Obstructive Pulmonary Disease.
Lim EY; Song EJ; Shin HS
J Microbiol Biotechnol; 2023 Sep; 33(9):1111-1118. PubMed ID: 37164760
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
Serban DE
Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
[TBL] [Abstract][Full Text] [Related]
19. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
20. Microbiota medicine: towards clinical revolution.
Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
